Technical Analysis for ZYME - Zymeworks Inc.

Grade Last Price % Change Price Change
grade B 17.64 -0.23% -0.04
ZYME closed down 0.23 percent on Friday, May 24, 2019, on 44 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical ZYME trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.23%
Lower Bollinger Band Touch Weakness -0.23%
Fell Below 20 DMA Bearish -0.11%
20 DMA Support Bullish -3.24%
NR7 Range Contraction -3.24%
Inside Day Range Contraction -3.24%
Crossed Above 20 DMA Bullish -4.34%
Fell Below 20 DMA Bearish -2.11%
Pocket Pivot Bullish Swing Setup -2.11%
NR7 Range Contraction -2.11%

Older signals for ZYME ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Zymeworks Inc is a Canada-based clinical-stage biopharmaceutical company. The Company focuses on the discovery, development and commercialization of multifunctional biotherapeutics. The Company's ZymeCAD platform is for protein modeling and structure-guided protein engineering. The Company's platforms include Azymetric Platform, AlbuCORE Platform, EFECT Platform and Zymelink Conjugation Platform + Cytotoxins. The Company's lead product candidate, ZW25, is a bispecific antibody, which is being evaluated in an adaptive Phase I clinical trial. Its ZW33 is a bi-specific antibody that delivers a cytotoxic payload to cancers cells by binding to different epitopes (bi-paratopic targeting) of the overexpressed HER2 protein. It focuses on developing a pipeline of preclinical product candidates and discovery-stage programs in immuno-oncology and other therapeutic areas. It analyzes protein characteristics to develop the scope of protein engineering to tackle biological systems.
Medicine Biopharmaceutical Medical Specialties Immunology Cancers Immune System Monoclonal Antibodies Cancer Immunotherapy Antibody Sutro Biopharma Glycoproteins Protein Engineering
Is ZYME a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.0
52 Week Low 10.72
Average Volume 144,981
200-Day Moving Average 14.9031
50-Day Moving Average 16.7588
20-Day Moving Average 18.3305
10-Day Moving Average 18.013
Average True Range 0.8832
ADX 14.73
+DI 22.9083
-DI 23.2893
Chandelier Exit (Long, 3 ATRs ) 16.9904
Chandelier Exit (Short, 3 ATRs ) 19.1196
Upper Bollinger Band 19.2936
Lower Bollinger Band 17.3674
Percent B (%b) 0.14
BandWidth 10.508169
MACD Line 0.2668
MACD Signal Line 0.4467
MACD Histogram -0.1799
Fundamentals Value
Market Cap 446.99 Million
Num Shares 25.3 Million
EPS -3.52
Price-to-Earnings (P/E) Ratio -5.01
Price-to-Sales 35.32
Price-to-Book 2.18
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.60
Resistance 3 (R3) 18.67 18.42 18.44
Resistance 2 (R2) 18.42 18.18 18.39 18.39
Resistance 1 (R1) 18.03 18.02 17.91 17.96 18.33
Pivot Point 17.78 17.78 17.72 17.75 17.78
Support 1 (S1) 17.39 17.54 17.27 17.32 16.95
Support 2 (S2) 17.14 17.38 17.11 16.89
Support 3 (S3) 16.75 17.14 16.84
Support 4 (S4) 16.68